• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡拉西坦可抑制慢性酒精摄入戒断期间海马神经元的丢失。

Piracetam impedes hippocampal neuronal loss during withdrawal after chronic alcohol intake.

作者信息

Brandão F, Paula-Barbosa M M, Cadete-Leite A

机构信息

Department of Anatomy, Porto Medical School, Portugal.

出版信息

Alcohol. 1995 May-Jun;12(3):279-88. doi: 10.1016/0741-8329(94)00107-o.

DOI:10.1016/0741-8329(94)00107-o
PMID:7639963
Abstract

In previous studies we have demonstrated that prolonged ethanol consumption induced hippocampal neuronal loss. In addition, we have shown that withdrawal after chronic alcohol intake augmented such degenerative activity leading to increased neuronal death in all subregions of the hippocampal formation but in the CA3 field. In an attempt to reverse this situation, we tested, during the withdrawal period, the effects of piracetam (2-oxo-1-pyrrolidine acetamide), a cyclic derivative of gamma-aminobutyric acid, as there is previous evidence that it might act as a neuronoprotective agent. The total number of dentate granule, hilar, and CA3 and CA1 pyramidal cells of the hippocampal formation were estimated using unbiased stereological methods. We found out that in animals treated with piracetam the numbers of dentate granule, hilar, and CA1 pyramidal cells were significantly higher than in pure withdrawn animals, and did not differ from those of alcohol-treated rats that did not undergo withdrawal. These data suggest that piracetam treatment impedes, during withdrawal, the pursuing of neuronal degeneration.

摘要

在先前的研究中,我们已经证明长期摄入乙醇会导致海马神经元丢失。此外,我们还表明,长期饮酒后戒断会加剧这种退行性活动,导致海马结构所有亚区(但CA3区除外)的神经元死亡增加。为了扭转这种情况,在戒断期间,我们测试了γ-氨基丁酸的环状衍生物吡拉西坦(2-氧代-1-吡咯烷乙酰胺)的作用,因为之前有证据表明它可能作为一种神经保护剂。使用无偏倚的体视学方法估计海马结构中齿状颗粒细胞、门区细胞以及CA3和CA1锥体细胞的总数。我们发现,用吡拉西坦治疗的动物中,齿状颗粒细胞、门区细胞和CA1锥体细胞的数量显著高于单纯戒断的动物,且与未戒断的酒精处理大鼠的细胞数量没有差异。这些数据表明,吡拉西坦治疗在戒断期间可阻止神经元变性的继续发展。

相似文献

1
Piracetam impedes hippocampal neuronal loss during withdrawal after chronic alcohol intake.吡拉西坦可抑制慢性酒精摄入戒断期间海马神经元的丢失。
Alcohol. 1995 May-Jun;12(3):279-88. doi: 10.1016/0741-8329(94)00107-o.
2
The GABAergic system of the dentate gyrus after withdrawal from chronic alcohol consumption: effects of intracerebral grafting and putative neuroprotective agents.长期饮酒戒断后齿状回的γ-氨基丁酸能系统:脑内移植和假定神经保护剂的作用
Alcohol Alcohol. 1997 Jul-Aug;32(4):471-84. doi: 10.1093/oxfordjournals.alcalc.a008282.
3
Piracetam promotes mossy fiber synaptic reorganization in rats withdrawn from alcohol.
Alcohol. 1996 May-Jun;13(3):239-49. doi: 10.1016/0741-8329(95)02050-0.
4
The effects of piracetam on lipofuscin of the rat cerebellar and hippocampal neurons after long-term alcohol treatment and withdrawal: a quantitative study.
Alcohol Clin Exp Res. 1991 Oct;15(5):834-8. doi: 10.1111/j.1530-0277.1991.tb00610.x.
5
Behavioral and neuroanatomical consequences of chronic ethanol intake and withdrawal.长期摄入乙醇及戒断后的行为和神经解剖学后果。
Physiol Behav. 1999 Apr;66(2):337-46. doi: 10.1016/s0031-9384(98)00301-1.
6
GM1 and piracetam do not revert the alcohol-induced depletion of cholinergic fibers in the hippocampal formation of the rat.GM1和吡拉西坦不能逆转酒精诱导的大鼠海马结构中胆碱能纤维的耗竭。
Alcohol. 1999 Aug;19(1):65-74. doi: 10.1016/s0741-8329(99)00026-9.
7
Effects of GM1 ganglioside upon neuronal degeneration during withdrawal from alcohol.
Alcohol. 1991 Nov-Dec;8(6):417-23. doi: 10.1016/s0741-8329(91)90017-q.
8
Structural changes in the hippocampal formation after long-term alcohol consumption and withdrawal in the rat.长期饮酒及戒断后大鼠海马结构的变化
Addiction. 1993 Feb;88(2):237-47. doi: 10.1111/j.1360-0443.1993.tb00807.x.
9
Alcohol withdrawal does not impede hippocampal granule cell progressive loss in chronic alcohol-fed rats.酒精戒断并不妨碍慢性酒精喂养大鼠海马颗粒细胞的渐进性丢失。
Neurosci Lett. 1988 Mar 21;86(1):45-50. doi: 10.1016/0304-3940(88)90180-2.
10
Effects of chronic alcohol consumption and withdrawal on the somatostatin-immunoreactive neurons of the rat hippocampal dentate hilus.长期饮酒及戒酒对大鼠海马齿状回门部生长抑素免疫反应性神经元的影响。
Hippocampus. 1992 Jan;2(1):65-71. doi: 10.1002/hipo.450020109.

引用本文的文献

1
Formulating treatment of major psychiatric disorders: algorithm targets the dominantly affected brain cell-types.制定主要精神疾病的治疗方案:算法针对主要受影响的脑细胞类型。
Discov Ment Health. 2023 Jan 5;3(1):3. doi: 10.1007/s44192-022-00029-8.
2
Cure of Alzheimer's Dementia Requires Addressing All of the Affected Brain Cell Types.治愈阿尔茨海默病性痴呆需要针对所有受影响的脑细胞类型。
J Clin Med. 2023 Mar 4;12(5):2049. doi: 10.3390/jcm12052049.
3
Supplementary Pharmacotherapy for the Behavioral Abnormalities Caused by Stressors in Humans, Focused on Post-Traumatic Stress Disorder (PTSD).
针对人类应激源所致行为异常的辅助药物治疗,重点关注创伤后应激障碍(PTSD)。
J Clin Med. 2023 Feb 20;12(4):1680. doi: 10.3390/jcm12041680.
4
Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.益智药作为认知增强剂:智能药物的类型、剂量和副作用。
Nutrients. 2022 Aug 17;14(16):3367. doi: 10.3390/nu14163367.
5
Neuroenhancement: State of the Art and Future Perspectives.神经增强:现状与未来展望。
Clin Neuropsychiatry. 2021 Jun;18(3):137-169. doi: 10.36131/cnfioritieditore20210303.
6
Probable Nootropicinduced Psychiatric Adverse Effects: A Series of Four Cases.可能由促智药引起的精神科不良反应:四例系列报道
Innov Clin Neurosci. 2015 Nov-Dec;12(11-12):21-5.
7
Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam.改善脑衰老和阿尔茨海默病中的线粒体功能——老一代代谢增强剂吡拉西坦的新作用机制
Front Neurosci. 2010 Sep 7;4. doi: 10.3389/fnins.2010.00044. eCollection 2010.
8
The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide.代谢增强剂吡拉西坦可改善β-淀粉样肽诱导的线粒体功能障碍和神经突生长受损。
Br J Pharmacol. 2010 May;160(2):246-57. doi: 10.1111/j.1476-5381.2010.00656.x. Epub 2010 Mar 9.
9
Piracetam: a review of pharmacological properties and clinical uses.吡拉西坦:药理特性与临床应用综述
CNS Drug Rev. 2005 Summer;11(2):169-82. doi: 10.1111/j.1527-3458.2005.tb00268.x.